Key result
Heart surgery for infective endocarditis is linked to ~31% lower follow-up mortality versus no surgery.
Why the study?
Although improvements have occurred over recent years, infective endocarditis remains a disease with high mortality and unclear long-term prognosis after treatment.
Does heart surgery reduce mortality in patients with infective endocarditis?
Cohort (n=132)
No
Does heart surgery reduce mortality in patients with infective endocarditis?
Absolute Event Rate: 36% vs 52%
p-value: p=0.04
Heart surgery for infective endocarditis is associated with reduced short- and intermediate-term mortality, though long-term mortality remains high and is driven by factors like age, prosthetic valve involvement, and S. aureus infection.
The outcome in 132 patients with infective endocarditis diagnosed in accordance with the Duke criteria at a tertiary hospital in Denmark in the period 1998-2000 is reported. The total in-hospital mortality was 15%. Indications are that in-hospital mortality over the last decade has been reduced by around a quarter. Mortality after 3 months was 17% (CI 29%), after 3 years 32% (CI 16-47%) and after 5 years 39% (CI 22-55%). This 5-years mortality was 5 times that of an age and gender matched background population. After follow-up for 5-8 y, mortality was highest for prosthetic valve endocarditis (63% vs. 39%, p = 0.05). Heart surgery was performed in 51% of the cases. Patients who underwent surgery had a lower mortality at follow-up (36% vs. 52%, p = 0.04). The 5-year mortality was 30% (CI 9-52%) for patients treated with surgery and 48% (CI 23-72%) for patients treated without surgery. In multivariable analysis surgery was not an independent predictor for lower long-term mortality. Surgery was however an independent predictor for lower intermediate-term mortality. It is concluded that surgery may be associated with lower short- and intermediate-term mortality, while the effect might decline in the long-term. High age, prosthetic valve endocarditis, and Staphylococcus aureus endocarditis were independent predictors for high mortality. Although improvements have occurred over recent years, infective endocarditis is still a high mortality disease.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2006) conducted a cohort in Infective endocarditis (n=132). Heart surgery vs. No surgery was evaluated on Mortality at follow-up (p=0.04). Heart surgery for infective endocarditis was associated with lower mortality at follow-up compared to no surgery (36% vs. 52%, p=0.04), though it was not an independent predictor long-term.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: